ArticleJournal of neurosurgery. Case lessons2025
Embolization of the middle meningeal artery for acute epidural hematoma: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute epidural hematoma (AEDH) is a life-threatening traumatic brain injury typically managed with emergency craniotomy. Endovascular embolization of the middle meningeal artery (MMA) is effective in controlling hemorrhage and preventing epidural hematoma evacuation. In previous studies, concomitant surgical interventions have been commonly applied for other intracranial lesions. Transarterial embolization (TAE), the only definitive treatment that can completely eliminate the need for surgery in all associated intracranial pathologies, is rarely performed. OBSERVATIONS: Here, the authors present the case of a 24-year-old female patient with AEDH who exhibited a leakage sign on CT angiography, which was indicative of active bleeding and possible hematoma expansion. Immediate MMA embolization was performed. Hemostasis was achieved using coils, without the need for surgical interventions. The patient had favorable outcomes, including resolution of headache, absence of neurological deficits, and complete hematoma regression at 1 month. Craniotomy was not performed, and the patient had high satisfaction in terms of cosmetic outcomes. LESSONS: TAE can be a safe and effective primary treatment for AEDH in some patients. In particular, it can completely prevent surgery and its associated morbidities. Early endovascular intervention for leakage signs should be promptly considered to achieve rapid hemostasis and prevent hematoma expansion, even with limited surgical access. https://thejns.org/doi/10.3171/CASE25521.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.